NFIL3
type: EnsemblDatabaseReference

227140_at
type: EFO_0005072
part of: A-AFFY-44

FCER1G
type: EnsemblDatabaseReference

MME UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.19541617906774
p value: 0.0366132827099035
refers to: 203434_s_at
refers to: MME
t statistic: 3.51534873036664

(Sample) clinical information/response to Infliximab treatment
type: EFO_0000001
property type: clinical information
property value: response to Infliximab treatment

SLC25A37 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.10056960397485
p value: 0.0226830271729626
refers to: 242335_at
refers to: SLC25A37
t statistic: 3.92451734901582

226847_at
type: EFO_0005072
part of: A-AFFY-44

235568_at
type: EFO_0005072
part of: A-AFFY-44

CREB5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.17419779211072
p value: 0.0176670081672424
refers to: CREB5
refers to: 232555_at
t statistic: 4.19703576818104

230170_at
type: EFO_0005072
part of: A-AFFY-44

CXCL5
type: EnsemblDatabaseReference

SIRPB1
type: EnsemblDatabaseReference

IL13RA2
type: EnsemblDatabaseReference

C10orf99 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.6709320885125
p value: 0.0494173845137561
refers to: C10orf99
refers to: 227736_at
t statistic: -3.25522367618386

WISP1
type: EnsemblDatabaseReference

207072_at
type: EFO_0005072
part of: A-AFFY-44

IDO1
type: EnsemblDatabaseReference

PAPPA
type: EnsemblDatabaseReference

IGFBP5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.25678978661616
p value: 0.0234267473480657
refers to: 203424_s_at
refers to: IGFBP5
t statistic: 3.9025490479833

205207_at
type: EFO_0005072
part of: A-AFFY-44

NFE2
type: EnsemblDatabaseReference

AOX1
type: EnsemblDatabaseReference

IGSF6
type: EnsemblDatabaseReference

IL1B
type: EnsemblDatabaseReference

209875_s_at
type: EFO_0005072
part of: A-AFFY-44

BCL2A1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.34018867747173
p value: 0.0112535122462482
refers to: BCL2A1
refers to: 205681_at
t statistic: 4.7564467056234

GPR27 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.3248198092997
p value: 0.0190693444146145
refers to: GPR27
refers to: 227769_at
t statistic: 4.0979353733754

MYO1F UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.02136007263841
p value: 0.0183460372784088
refers to: 213733_at
refers to: MYO1F
t statistic: 4.15473014129096

229435_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P10/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

C5AR1
type: EnsemblDatabaseReference

227769_at
type: EFO_0005072
part of: A-AFFY-44

FCGR3B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.22804965237382
p value: 0.00932415423122688
refers to: FCGR3B
refers to: 204007_at
t statistic: 4.93335277224848

211806_s_at
type: EFO_0005072
part of: A-AFFY-44

CSGALNACT1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2443817943878
p value: 0.0237905572518576
refers to: CSGALNACT1
refers to: 219049_at
t statistic: 3.88708755325109

RGS18
type: EnsemblDatabaseReference

PROK2
type: EnsemblDatabaseReference

203574_at
type: EFO_0005072
part of: A-AFFY-44

229831_at
type: EFO_0005072
part of: A-AFFY-44

EREG
type: EnsemblDatabaseReference

GPR97
type: EnsemblDatabaseReference

TNFAIP3
type: EnsemblDatabaseReference

204748_at
type: EFO_0005072
part of: A-AFFY-44

APOBEC3A
type: EnsemblDatabaseReference

MME
type: EnsemblDatabaseReference

STEAP4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.70416885321392
p value: 0.00881466620094704
refers to: STEAP4
refers to: 225987_at
t statistic: 4.98056900746665

ZEB2
type: EnsemblDatabaseReference

CEMIP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.2563365680966
p value: 0.005112120609938
refers to: CEMIP
refers to: 212942_s_at
t statistic: 5.6805161463722

PFKFB3
type: EnsemblDatabaseReference

P2RY13 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.31889366853977
p value: 0.0144204803888178
refers to: P2RY13
refers to: 220005_at
t statistic: 4.39131079881667

HAL
type: EnsemblDatabaseReference

WNT5A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.49302312648196
p value: 0.00810370720716641
refers to: WNT5A
refers to: 205990_s_at
t statistic: 5.12784616830396

F5
type: EnsemblDatabaseReference

ACSL4
type: EnsemblDatabaseReference

227152_at
type: EFO_0005072
part of: A-AFFY-44

PLEK
type: EnsemblDatabaseReference

IL13RA2
type: EnsemblDatabaseReference

TWIST2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.11947398268415
p value: 0.0200424130152393
refers to: TWIST2
refers to: 229404_at
t statistic: 4.0402339867114

(Assay) P34/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

210868_s_at
type: EFO_0005072
part of: A-AFFY-44

HCK UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15343530063371
p value: 0.0313295322375933
refers to: HCK
refers to: 208018_s_at
t statistic: 3.63876540680967

AOX1
type: EnsemblDatabaseReference

209960_at
type: EFO_0005072
part of: A-AFFY-44

B3GNT7
type: EnsemblDatabaseReference

CNTN3
type: EnsemblDatabaseReference

MCTP1
type: EnsemblDatabaseReference

ALOX5AP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2376183662366
p value: 0.0265487481854735
refers to: 204174_at
refers to: ALOX5AP
t statistic: 3.78405455145213

206211_at
type: EFO_0005072
part of: A-AFFY-44

203424_s_at
type: EFO_0005072
part of: A-AFFY-44

212942_s_at
type: EFO_0005072
part of: A-AFFY-44

PROK2
type: EnsemblDatabaseReference

202643_s_at
type: EFO_0005072
part of: A-AFFY-44

223809_at
type: EFO_0005072
part of: A-AFFY-44

COL12A1
type: EnsemblDatabaseReference

SOCS3
type: EnsemblDatabaseReference

209277_at
type: EFO_0005072
part of: A-AFFY-44

IL24 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.88009483228793
p value: 0.0141340591590379
refers to: IL24
refers to: 206569_at
t statistic: 4.45815032661086

204994_at
type: EFO_0005072
part of: A-AFFY-44

SLC2A3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.5764398210081
p value: 0.0159686236533819
refers to: SLC2A3
refers to: 202497_x_at
t statistic: 4.29810536644075

MYO1F
type: EnsemblDatabaseReference

PTGS2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.90662661077442
p value: 0.00413541586804458
refers to: PTGS2
refers to: 1554997_a_at
t statistic: 5.88380300301311

FGR
type: EnsemblDatabaseReference

INHBA
type: EnsemblDatabaseReference

242907_at
type: EFO_0005072
part of: A-AFFY-44

CLEC7A
type: EnsemblDatabaseReference

229947_at
type: EFO_0005072
part of: A-AFFY-44

204959_at
type: EFO_0005072
part of: A-AFFY-44

SRGN
type: EnsemblDatabaseReference

FAM129A
type: EnsemblDatabaseReference

BCL2A1
type: EnsemblDatabaseReference

KCNJ2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.08799826942602
p value: 0.0275242048234573
refers to: KCNJ2
refers to: 206765_at
t statistic: 3.75352624615638

DUSP1
type: EnsemblDatabaseReference

COL7A1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.23126395282001
p value: 0.0255793981254183
refers to: COL7A1
refers to: 217312_s_at
t statistic: 3.82655949039716

TMEM71 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.41881093438743
p value: 0.0183460372784088
refers to: 238429_at
refers to: TMEM71
t statistic: 4.15781375397746

SLC11A1
type: EnsemblDatabaseReference

IL11
type: EnsemblDatabaseReference

HSD11B1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.24853260740616
p value: 0.0185924735288708
refers to: 205404_at
refers to: HSD11B1
t statistic: 4.12490849763408

KYNU
type: EnsemblDatabaseReference

206924_at
type: EFO_0005072
part of: A-AFFY-44

CXCL8
type: EnsemblDatabaseReference

204597_x_at
type: EFO_0005072
part of: A-AFFY-44

NFE2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.66450110331179
p value: 0.0176287365546534
refers to: 209930_s_at
refers to: NFE2
t statistic: 4.20441286313674

CLEC4E
type: EnsemblDatabaseReference

TLR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.45587804889899
p value: 0.026483334203047
refers to: 210176_at
refers to: TLR1
t statistic: 3.7911941459163

206172_at
type: EFO_0005072
part of: A-AFFY-44

KIAA1551 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.07088091728996
p value: 0.0371412039500742
refers to: KIAA1551
refers to: 227152_at
t statistic: 3.49952596401452

IL1RN UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.02586451537981
p value: 0.00547948153820272
refers to: IL1RN
refers to: 216243_s_at
t statistic: 5.52278015387007

CDHR1
type: EnsemblDatabaseReference

205067_at
type: EFO_0005072
part of: A-AFFY-44

FGR
type: EnsemblDatabaseReference

SELE
type: EnsemblDatabaseReference

HGF
type: EnsemblDatabaseReference

INHBA
type: EnsemblDatabaseReference

SOD2
type: EnsemblDatabaseReference

LILRA5
type: EnsemblDatabaseReference

SRGN
type: EnsemblDatabaseReference

CXCL11 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.15796337826505
p value: 0.011036959102767
refers to: CXCL11
refers to: 211122_s_at
t statistic: 4.80170235647333

204422_s_at
type: EFO_0005072
part of: A-AFFY-44

TLR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46239863781403
p value: 0.00610411881782526
refers to: 204924_at
refers to: TLR2
t statistic: 5.35915820957885

FAM129A
type: EnsemblDatabaseReference

205786_s_at
type: EFO_0005072
part of: A-AFFY-44

COL12A1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.05589298545357
p value: 0.0413128391727247
refers to: COL12A1
refers to: 231879_at
t statistic: 3.40266049626352

OLFM1
type: EnsemblDatabaseReference

FGR UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.27784888004464
p value: 0.0130110983686065
refers to: FGR
refers to: 208438_s_at
t statistic: 4.56012476391647

206420_at
type: EFO_0005072
part of: A-AFFY-44

DUSP1
type: EnsemblDatabaseReference

TWIST2
type: EnsemblDatabaseReference

KCNJ15 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.27778718338329
p value: 0.0133921673732828
refers to: KCNJ15
refers to: 211806_s_at
t statistic: 4.49224380403063

TFPI2
type: EnsemblDatabaseReference

216243_s_at
type: EFO_0005072
part of: A-AFFY-44

CSF3R
type: EnsemblDatabaseReference

210029_at
type: EFO_0005072
part of: A-AFFY-44

CCL4
type: EnsemblDatabaseReference

OLFM1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.10416067388942
p value: 0.0202552260429819
refers to: 213131_at
refers to: OLFM1
t statistic: 4.02074491954841

IL6
type: EnsemblDatabaseReference

(Sample) organism part/colon
type: UBERON_0001155
property type: organism part
property value: colon

206522_at
type: EFO_0005072
part of: A-AFFY-44

SOD2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.23615129318848
p value: 0.0159971351644384
refers to: 216841_s_at
refers to: SOD2
t statistic: 4.28912721849185

S100A12
type: EnsemblDatabaseReference

CLEC4E
type: EnsemblDatabaseReference

CHI3L1
type: EnsemblDatabaseReference

CXCL14 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09450663781027
p value: 0.0202552260429819
refers to: 222484_s_at
refers to: CXCL14
t statistic: -4.01917422571974

221874_at
type: EFO_0005072
part of: A-AFFY-44

210484_s_at
type: EFO_0005072
part of: A-AFFY-44

TNFRSF10C
type: EnsemblDatabaseReference

THBS2
type: EnsemblDatabaseReference

HGF UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.17265061018136
p value: 0.016079694876486
refers to: HGF
refers to: 210997_at
t statistic: 4.2831050766394

MMP3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.53638433444342
p value: 0.0349267984044948
refers to: MMP3
refers to: 205828_at
t statistic: 3.55848866257681

204595_s_at
type: EFO_0005072
part of: A-AFFY-44

HAPLN1 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.21583144819228
p value: 0.0159686236533819
refers to: HAPLN1
refers to: 205523_at
t statistic: -4.29109309264728

TNFAIP6
type: EnsemblDatabaseReference

217388_s_at
type: EFO_0005072
part of: A-AFFY-44

CCR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.16212934201231
p value: 0.0236526986837194
refers to: CCR1
refers to: 205098_at
t statistic: 3.89331471662524

220404_at
type: EFO_0005072
part of: A-AFFY-44

Analysis of 'no response to Infliximab' vs 'response to Infliximab treatment'
type: MicroarrayDifferentialExpressionAnalysis

GPR27
type: EnsemblDatabaseReference

BCL6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.09313169073874
p value: 0.0313295322375933
refers to: BCL6
refers to: 215990_s_at
t statistic: 3.64415880411859

WFDC2
type: EnsemblDatabaseReference

LCP2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.21702889810664
p value: 0.0297203061380308
refers to: LCP2
refers to: 205270_s_at
t statistic: 3.69169935260317

GCA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.3341217370552
p value: 0.0148691056634883
refers to: GCA
refers to: 203765_at
t statistic: 4.35208595232477

TAGAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.94515619580851
p value: 0.0107551643470971
refers to: TAGAP
refers to: 229723_at
t statistic: 4.82807931128803

204007_at
type: EFO_0005072
part of: A-AFFY-44

203083_at
type: EFO_0005072
part of: A-AFFY-44

232224_at
type: EFO_0005072
part of: A-AFFY-44

207080_s_at
type: EFO_0005072
part of: A-AFFY-44

ITGAX
type: EnsemblDatabaseReference

201858_s_at
type: EFO_0005072
part of: A-AFFY-44

FCER1G UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.238445590019
p value: 0.0175065238208476
refers to: 1554899_s_at
refers to: FCER1G
t statistic: 4.2115043612283

ALPL UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.4768595396847
p value: 0.0214591376223797
refers to: 215783_s_at
refers to: ALPL
t statistic: 3.97162354070632

(Assay) P14/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

E-GEOD-12251
type: microarray 1colour mrna differential
RO_0002162: Homo sapiens
description: Infliximab, an anti-TNFa monoclonal antibody, is an effective treatment for ulcerative colitis (UC) inducing over 60% of patients to respond to treatment. Consequently, about 40% of patients do not respond. This study analyzed mucosal gene expression from patients enrolled in ACT1 to provide a predictive response signature for infliximab treatment. Experiment Overall Design: Twenty-two patients underwent colonoscopy with biopsy before infliximab treatment. Response to infliximab was defined as endoscopic and histologic healing at week 8 (P2, 5, 9, 10, 14, 15, 16, 17, 24, 27, 36, and 45 as responders; P3, 12, 13, 19, 28, 29, 32, 33, 34, and 47 as non-responders). Messenger RNA was isolated from pre-infliximab biopsies, labeled and hybridized to Affymetrix HGU133Plus_2.0 Array. The predictive response signature was verified by an independent data set.
uses data from: http://identifiers.org/pubmed/19700435

IL6
type: EnsemblDatabaseReference

207890_s_at
type: EFO_0005072
part of: A-AFFY-44

OLR1
type: EnsemblDatabaseReference

207442_at
type: EFO_0005072
part of: A-AFFY-44

FPR1
type: EnsemblDatabaseReference

CLEC4E UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.72369756450909
p value: 0.004200955667433
refers to: CLEC4E
refers to: 222934_s_at
t statistic: 5.85794010691303

CXCL11
type: EnsemblDatabaseReference

213425_at
type: EFO_0005072
part of: A-AFFY-44

SOSTDC1 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.30256022994926
p value: 0.0379124584351149
refers to: 213456_at
refers to: SOSTDC1
t statistic: -3.47946508042808

S100A12
type: EnsemblDatabaseReference

1552542_s_at
type: EFO_0005072
part of: A-AFFY-44

IGFBP5
type: EnsemblDatabaseReference

204596_s_at
type: EFO_0005072
part of: A-AFFY-44

MASP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.40865800840652
p value: 0.00525222016411487
refers to: 232224_at
refers to: MASP1
t statistic: 5.6573848098664

HSD11B1
type: EnsemblDatabaseReference

204933_s_at
type: EFO_0005072
part of: A-AFFY-44

202888_s_at
type: EFO_0005072
part of: A-AFFY-44

HAPLN1 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07161604349642
p value: 0.0258775634982868
refers to: HAPLN1
refers to: 230204_at
t statistic: -3.81236741501779

LRRK2
type: EnsemblDatabaseReference

DOK3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.11658424152306
p value: 0.0473720981255039
refers to: DOK3
refers to: 223553_s_at
t statistic: 3.28949799952781

BCL6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.59480480925367
p value: 0.00530847066770928
refers to: BCL6
refers to: 203140_at
t statistic: 5.63804584333489

1555962_at
type: EFO_0005072
part of: A-AFFY-44

TNFAIP6
type: EnsemblDatabaseReference

KCNJ15
type: EnsemblDatabaseReference

VNN2
type: EnsemblDatabaseReference

(Factor value) CLINICAL_INFORMATION/response to Infliximab treatment
type: EFO_0000001
property type: CLINICAL_INFORMATION
property value: response to Infliximab treatment

NRCAM
type: EnsemblDatabaseReference

MASP1
type: EnsemblDatabaseReference

IFIT2
type: EnsemblDatabaseReference

GBP5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.40048552461359
p value: 0.0200992194290112
refers to: GBP5
refers to: 229625_at
t statistic: 4.03285542695354

234050_at
type: EFO_0005072
part of: A-AFFY-44

CMTM2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.80363733154705
p value: 0.00817292338038492
refers to: CMTM2
refers to: 229967_at
t statistic: 5.10715301865242

LGR5
type: EnsemblDatabaseReference

ACSL1
type: EnsemblDatabaseReference

223767_at
type: EFO_0005072
part of: A-AFFY-44

229967_at
type: EFO_0005072
part of: A-AFFY-44

S100A8
type: EnsemblDatabaseReference

202388_at
type: EFO_0005072
part of: A-AFFY-44

TNFAIP6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.50050562648867
p value: 0.00547948153820272
refers to: 206025_s_at
refers to: TNFAIP6
t statistic: 5.50895888613127

CLEC7A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22396534239746
p value: 0.0176670081672424
refers to: CLEC7A
refers to: 221698_s_at
t statistic: 4.19417665982121

204714_s_at
type: EFO_0005072
part of: A-AFFY-44

APOBEC3A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.75399946478269
p value: 0.00403123741785531
refers to: 210873_x_at
refers to: APOBEC3A
t statistic: 6.04991552587546

ANPEP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.76463885642232
p value: 0.0182041491223306
refers to: ANPEP
refers to: 202888_s_at
t statistic: 4.17160074333176

TLR4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.25494171118553
p value: 0.00787805065620863
refers to: 232068_s_at
refers to: TLR4
t statistic: 5.19682345839202

SOD2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.02079229701534
p value: 0.0175846372734422
refers to: SOD2
refers to: 221477_s_at
t statistic: 4.20660675009031

IGFBP5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.1152333216171
p value: 0.0365318401940226
refers to: IGFBP5
refers to: 211958_at
t statistic: 3.51804381706844

HCK
type: EnsemblDatabaseReference

1552773_at
type: EFO_0005072
part of: A-AFFY-44

TNFRSF11B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.94474385804236
p value: 0.00257913486187158
refers to: TNFRSF11B
refers to: 204933_s_at
t statistic: 7.26372894029057

TFPI
type: EnsemblDatabaseReference

208018_s_at
type: EFO_0005072
part of: A-AFFY-44

242388_x_at
type: EFO_0005072
part of: A-AFFY-44

1554997_a_at
type: EFO_0005072
part of: A-AFFY-44

SAMSN1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22755183885784
p value: 0.0390922501890582
refers to: 1555638_a_at
refers to: SAMSN1
t statistic: 3.45486410974837

204103_at
type: EFO_0005072
part of: A-AFFY-44

ACSL1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.1386213347378
p value: 0.00610411881782526
refers to: 207275_s_at
refers to: ACSL1
t statistic: 5.34899518018945

HOXD11
type: EnsemblDatabaseReference

TLR4
type: EnsemblDatabaseReference

SOCS3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.63882456967207
p value: 0.0148691056634883
refers to: SOCS3
refers to: 227697_at
t statistic: 4.34923309992779

SLC16A10
type: EnsemblDatabaseReference

FPR2
type: EnsemblDatabaseReference

215783_s_at
type: EFO_0005072
part of: A-AFFY-44

SPP1
type: EnsemblDatabaseReference

(Assay) P5/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

PTGES
type: EnsemblDatabaseReference

BASP1
type: EnsemblDatabaseReference

MMP3
type: EnsemblDatabaseReference

STC1
type: EnsemblDatabaseReference

217312_s_at
type: EFO_0005072
part of: A-AFFY-44

LILRB2
type: EnsemblDatabaseReference

CXCL14 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1893581594022
p value: 0.0289401241560303
refers to: CXCL14
refers to: 218002_s_at
t statistic: -3.71590537462551

PI15 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 3.41813866438583
p value: 0.00828010328609606
refers to: 229947_at
refers to: PI15
t statistic: 5.02316391971013

TLR1
type: EnsemblDatabaseReference

MMP25 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00619747627261
p value: 0.0166179186992133
refers to: MMP25
refers to: 207890_s_at
t statistic: 4.24931651052158

FPR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.28495062634003
p value: 0.00547948153820272
refers to: FPR2
refers to: 210772_at
t statistic: 5.55090422492704

B3GNT7 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.2021089877725
p value: 0.02127587020655
refers to: B3GNT7
refers to: 1555963_x_at
t statistic: -3.97986397335707

205931_s_at
type: EFO_0005072
part of: A-AFFY-44

KCNJ15 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.07580385721447
p value: 0.0112535122462482
refers to: KCNJ15
refers to: 230585_at
t statistic: 4.76052966876114

ACSL1
type: EnsemblDatabaseReference

219825_at
type: EFO_0005072
part of: A-AFFY-44

220014_at
type: EFO_0005072
part of: A-AFFY-44

209395_at
type: EFO_0005072
part of: A-AFFY-44

TREM1
type: EnsemblDatabaseReference

LILRA5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.25734281558549
p value: 0.0243404696975075
refers to: LILRA5
refers to: 1555643_s_at
t statistic: 3.86770634525254

1556185_a_at
type: EFO_0005072
part of: A-AFFY-44

ELOVL6
type: EnsemblDatabaseReference

213435_at
type: EFO_0005072
part of: A-AFFY-44

OSM UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.61051492622131
p value: 0.00403123741785531
refers to: 230170_at
refers to: OSM
t statistic: 6.15065500365168

FPR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.20860400439773
p value: 0.00490607677757389
refers to: FPR1
refers to: 205119_s_at
t statistic: 5.70978350083193

HLA-DQA1
type: EnsemblDatabaseReference

FCN1
type: EnsemblDatabaseReference

HAL UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.26435914049219
p value: 0.0348866275839241
refers to: 206643_at
refers to: HAL
t statistic: 3.55937411323486

SLC11A1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.63475532076911
p value: 0.00828010328609606
refers to: 210423_s_at
refers to: SLC11A1
t statistic: 5.02092648611059

(Assay) P45/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

TFPI2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.43953239276648
p value: 0.0165839556599434
refers to: 209278_s_at
refers to: TFPI2
t statistic: 4.25122314165669

TLR4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.35212697107529
p value: 0.00610411881782526
refers to: TLR4
refers to: 224341_x_at
t statistic: 5.35600962023146

TNFAIP3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15726931958611
p value: 0.0143276017267149
refers to: TNFAIP3
refers to: 202643_s_at
t statistic: 4.41721439188913

222939_s_at
type: EFO_0005072
part of: A-AFFY-44

229450_at
type: EFO_0005072
part of: A-AFFY-44

PTPRO
type: EnsemblDatabaseReference

IL18RAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.85478811080422
p value: 0.00810370720716641
refers to: IL18RAP
refers to: 207072_at
t statistic: 5.1542104685496

203892_at
type: EFO_0005072
part of: A-AFFY-44

TLR4
type: EnsemblDatabaseReference

TAGAP
type: EnsemblDatabaseReference

205523_at
type: EFO_0005072
part of: A-AFFY-44

AQP9
type: EnsemblDatabaseReference

COL8A1
type: EnsemblDatabaseReference

(Sample) clinical information/no response to Infliximab
type: EFO_0000001
property type: clinical information
property value: no response to Infliximab

(Assay) P47/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

TLR8
type: EnsemblDatabaseReference

GBP5
type: EnsemblDatabaseReference

STEAP4
type: EnsemblDatabaseReference

RGS18 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.12758800267681
p value: 0.040869957396575
refers to: RGS18
refers to: 223809_at
t statistic: 3.41083718555497

B3GNT7 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0558383928548
p value: 0.0199529657989892
refers to: B3GNT7
refers to: 1555962_at
t statistic: -4.049356410807

SPP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.75291631616137
p value: 0.0141340591590379
refers to: SPP1
refers to: 209875_s_at
t statistic: 4.45918321275203

GBP2
type: EnsemblDatabaseReference

213880_at
type: EFO_0005072
part of: A-AFFY-44

210118_s_at
type: EFO_0005072
part of: A-AFFY-44

224341_x_at
type: EFO_0005072
part of: A-AFFY-44

210184_at
type: EFO_0005072
part of: A-AFFY-44

SOD2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.45264406448763
p value: 0.0141340591590379
refers to: 215223_s_at
refers to: SOD2
t statistic: 4.44298437692964

FCN1
type: EnsemblDatabaseReference

SERPINB2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.13746647923065
p value: 0.0222911708564283
refers to: SERPINB2
refers to: 204614_at
t statistic: 3.93861408243145

FAM129A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.17337540546882
p value: 0.0256783189883894
refers to: FAM129A
refers to: 217967_s_at
t statistic: 3.81685891948015

206359_at
type: EFO_0005072
part of: A-AFFY-44

210773_s_at
type: EFO_0005072
part of: A-AFFY-44

CHI3L1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.85580174031157
p value: 0.0265487481854735
refers to: 209396_s_at
refers to: CHI3L1
t statistic: 3.78225436948468

IFIT3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2443066543227
p value: 0.0295431799508845
refers to: 229450_at
refers to: IFIT3
t statistic: 3.69558682106684

205990_s_at
type: EFO_0005072
part of: A-AFFY-44

210146_x_at
type: EFO_0005072
part of: A-AFFY-44

222484_s_at
type: EFO_0005072
part of: A-AFFY-44

CREB5
type: EnsemblDatabaseReference

IL1A
type: EnsemblDatabaseReference

217966_s_at
type: EFO_0005072
part of: A-AFFY-44

210367_s_at
type: EFO_0005072
part of: A-AFFY-44

PTPRO
type: EnsemblDatabaseReference

KCNJ2
type: EnsemblDatabaseReference

P2RY13
type: EnsemblDatabaseReference

DOK3
type: EnsemblDatabaseReference

238581_at
type: EFO_0005072
part of: A-AFFY-44

227736_at
type: EFO_0005072
part of: A-AFFY-44

TAGAP
type: EnsemblDatabaseReference

205234_at
type: EFO_0005072
part of: A-AFFY-44

215078_at
type: EFO_0005072
part of: A-AFFY-44

230204_at
type: EFO_0005072
part of: A-AFFY-44

THBS2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.28484226118216
p value: 0.0289401241560303
refers to: 203083_at
refers to: THBS2
t statistic: 3.71609815977305

CTHRC1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.39745234061512
p value: 0.030220201567005
refers to: 225681_at
refers to: CTHRC1
t statistic: 3.67664756496647

1554899_s_at
type: EFO_0005072
part of: A-AFFY-44

KLK10
type: EnsemblDatabaseReference

(Assay) P36/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

202627_s_at
type: EFO_0005072
part of: A-AFFY-44

IL18RAP
type: EnsemblDatabaseReference

KIAA1324
type: EnsemblDatabaseReference

229228_at
type: EFO_0005072
part of: A-AFFY-44

C10orf99
type: EnsemblDatabaseReference

GAS1
type: EnsemblDatabaseReference

BCL6
type: EnsemblDatabaseReference

211302_s_at
type: EFO_0005072
part of: A-AFFY-44

205681_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P24/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

PYY
type: EnsemblDatabaseReference

ALOX5AP
type: EnsemblDatabaseReference

236203_at
type: EFO_0005072
part of: A-AFFY-44

NAMPT UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.28513287197848
p value: 0.00413541586804458
refers to: NAMPT
refers to: 243296_at
t statistic: 5.91582784163947

CSF2RB
type: EnsemblDatabaseReference

PTCH1
type: EnsemblDatabaseReference

217967_s_at
type: EFO_0005072
part of: A-AFFY-44

NCF2
type: EnsemblDatabaseReference

213131_at
type: EFO_0005072
part of: A-AFFY-44

GPR97 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.24816944587403
p value: 0.0120550525357693
refers to: GPR97
refers to: 220404_at
t statistic: 4.69396073938541

FST UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46233902102208
p value: 0.0130552135255175
refers to: FST
refers to: 226847_at
t statistic: 4.53545757037196

213524_s_at
type: EFO_0005072
part of: A-AFFY-44

213943_at
type: EFO_0005072
part of: A-AFFY-44

KIAA1551
type: EnsemblDatabaseReference

IL13RA2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.17897430508102
p value: 0.0171229686515731
refers to: 206172_at
refers to: IL13RA2
t statistic: 4.22600645068845

SLC2A3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.8939064695245
p value: 0.0180308194216794
refers to: SLC2A3
refers to: 202499_s_at
t statistic: 4.18036166425053

MX2
type: EnsemblDatabaseReference

(Assay) P3/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

KCNJ2
type: EnsemblDatabaseReference

RP3-428L16.2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.07522608108838
p value: 0.02127587020655
refers to: 238623_at
refers to: RP3-428L16.2
t statistic: 3.97794848069183

205896_at
type: EFO_0005072
part of: A-AFFY-44

WFDC2 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.23027474393479
p value: 0.0373949005367731
refers to: 203892_at
refers to: WFDC2
t statistic: -3.49123934359059

RP11-373D23.2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.01335802011148
p value: 0.0186240681667536
refers to: RP11-373D23.2
refers to: 241824_at
t statistic: 4.11881176552497

1555643_s_at
type: EFO_0005072
part of: A-AFFY-44

FCER1G
type: EnsemblDatabaseReference

G0S2
type: EnsemblDatabaseReference

SELL UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.71618129959999
p value: 0.0190737279902017
refers to: SELL
refers to: 204563_at
t statistic: 4.09533211735016

CXCR2
type: EnsemblDatabaseReference

PTPRO DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05099180903865
p value: 0.0183460372784088
refers to: PTPRO
refers to: 208121_s_at
t statistic: -4.15196157972129

CYP4F3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46881612137456
p value: 0.013291992710329
refers to: CYP4F3
refers to: 206515_at
t statistic: 4.49684786016103

202628_s_at
type: EFO_0005072
part of: A-AFFY-44

PTGS2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.74786811740776
p value: 0.00403123741785531
refers to: PTGS2
refers to: 204748_at
t statistic: 6.04984807936806

ITGAX UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.07107603953982
p value: 0.0206858049126579
refers to: ITGAX
refers to: 210184_at
t statistic: 4.00420294422129

227697_at
type: EFO_0005072
part of: A-AFFY-44

GAS1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.49553839038405
p value: 0.0144204803888178
refers to: 204457_s_at
refers to: GAS1
t statistic: 4.37713015355025

CREB5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.3596428285083
p value: 0.0182959842004943
refers to: CREB5
refers to: 205931_s_at
t statistic: 4.16470422472798

SLC22A4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.23496028220634
p value: 0.00988418272501068
refers to: 205896_at
refers to: SLC22A4
t statistic: 4.88877410188458

IL24
type: EnsemblDatabaseReference

229560_at
type: EFO_0005072
part of: A-AFFY-44

PAPPA
type: EnsemblDatabaseReference

224941_at
type: EFO_0005072
part of: A-AFFY-44

TREM1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.3680545237488
p value: 0.00547948153820272
refers to: TREM1
refers to: 219434_at
t statistic: 5.51861184344821

220122_at
type: EFO_0005072
part of: A-AFFY-44

G0S2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.43785771315926
p value: 0.00403123741785531
refers to: 213524_s_at
refers to: G0S2
t statistic: 6.16203739183702

LILRB2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.06997327796653
p value: 0.0165839556599434
refers to: LILRB2
refers to: 207697_x_at
t statistic: 4.25417521959262

215990_s_at
type: EFO_0005072
part of: A-AFFY-44

IGSF6
type: EnsemblDatabaseReference

IL1B
type: EnsemblDatabaseReference

FCN1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.94764810770908
p value: 0.00828010328609606
refers to: FCN1
refers to: 205237_at
t statistic: 5.0253014076465

GAS1
type: EnsemblDatabaseReference

214604_at
type: EFO_0005072
part of: A-AFFY-44

204174_at
type: EFO_0005072
part of: A-AFFY-44

205098_at
type: EFO_0005072
part of: A-AFFY-44

HLA-DQA1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.85183565554963
p value: 0.0473720981255039
refers to: HLA-DQA1
refers to: 236203_at
t statistic: 3.2893298391903

204924_at
type: EFO_0005072
part of: A-AFFY-44

ALPL
type: EnsemblDatabaseReference

GPR97
type: EnsemblDatabaseReference

NAMPT
type: EnsemblDatabaseReference

232555_at
type: EFO_0005072
part of: A-AFFY-44

HAPLN1
type: EnsemblDatabaseReference

SLC16A6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.23136233621844
p value: 0.0144204803888178
refers to: 230748_at
refers to: SLC16A6
t statistic: 4.38785500007714

221698_s_at
type: EFO_0005072
part of: A-AFFY-44

APOBEC3A
type: EnsemblDatabaseReference

MME
type: EnsemblDatabaseReference

ZEB2
type: EnsemblDatabaseReference

203434_s_at
type: EFO_0005072
part of: A-AFFY-44

TFPI UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.0772950673395
p value: 0.00481152921127824
refers to: 210664_s_at
refers to: TFPI
t statistic: 5.76429225392536

CXCL14
type: EnsemblDatabaseReference

CYP4F3
type: EnsemblDatabaseReference

PFKFB3
type: EnsemblDatabaseReference

205099_s_at
type: EFO_0005072
part of: A-AFFY-44

215838_at
type: EFO_0005072
part of: A-AFFY-44

G0S2
type: EnsemblDatabaseReference

CXCR2
type: EnsemblDatabaseReference

FAM129A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.10165725508466
p value: 0.0291891655234211
refers to: FAM129A
refers to: 217966_s_at
t statistic: 3.70640638898424

MCEMP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.93447157848764
p value: 0.018704023232986
refers to: 235568_at
refers to: MCEMP1
t statistic: 4.11134209186213

PRR16
type: EnsemblDatabaseReference

CREB5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.47422238192665
p value: 0.0129663163420386
refers to: CREB5
refers to: 229228_at
t statistic: 4.57390222058534

219049_at
type: EFO_0005072
part of: A-AFFY-44

PLEK
type: EnsemblDatabaseReference

210511_s_at
type: EFO_0005072
part of: A-AFFY-44

242335_at
type: EFO_0005072
part of: A-AFFY-44

CSF3R UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.40239557411853
p value: 0.00403123741785531
refers to: 203591_s_at
refers to: CSF3R
t statistic: 6.32285729769693

FAP
type: EnsemblDatabaseReference

229625_at
type: EFO_0005072
part of: A-AFFY-44

220330_s_at
type: EFO_0005072
part of: A-AFFY-44

RNF144B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.02822137864909
p value: 0.0351703454020955
refers to: RNF144B
refers to: 228153_at
t statistic: 3.55096892362034

GIPC2 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00377876978625
p value: 0.027193564457441
refers to: 219970_at
refers to: GIPC2
t statistic: -3.76284281900622

CCR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.29895525431736
p value: 0.0201189842670217
refers to: CCR1
refers to: 205099_s_at
t statistic: 4.02897499254341

F5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15707882465682
p value: 0.0244177384253518
refers to: 204714_s_at
refers to: F5
t statistic: 3.86273711813574

TWIST1
type: EnsemblDatabaseReference

202391_at
type: EFO_0005072
part of: A-AFFY-44

MCTP1
type: EnsemblDatabaseReference

LILRA2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.0636867661913
p value: 0.0130179494012249
refers to: 211101_x_at
refers to: LILRA2
t statistic: 4.54084388773609

NRCAM UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22466239126752
p value: 0.0197001875767615
refers to: NRCAM
refers to: 204105_s_at
t statistic: 4.06627927095245

COL12A1
type: EnsemblDatabaseReference

203435_s_at
type: EFO_0005072
part of: A-AFFY-44

SOCS3
type: EnsemblDatabaseReference

CNTN3 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.42330050503192
p value: 0.0153613113309796
refers to: CNTN3
refers to: 229831_at
t statistic: -4.33174502089345

223553_s_at
type: EFO_0005072
part of: A-AFFY-44

RGS2
type: EnsemblDatabaseReference

232481_s_at
type: EFO_0005072
part of: A-AFFY-44

MYO1F
type: EnsemblDatabaseReference

207674_at
type: EFO_0005072
part of: A-AFFY-44

SATB2 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05179355985223
p value: 0.0431770812770303
refers to: SATB2
refers to: 213435_at
t statistic: -3.37089654786161

GBP5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.61679008628027
p value: 0.0144204803888178
refers to: 238581_at
refers to: GBP5
t statistic: 4.3746945269234

206569_at
type: EFO_0005072
part of: A-AFFY-44

CLEC7A
type: EnsemblDatabaseReference

LILRA2
type: EnsemblDatabaseReference

(Assay) P2/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

212657_s_at
type: EFO_0005072
part of: A-AFFY-44

226237_at
type: EFO_0005072
part of: A-AFFY-44

204575_s_at
type: EFO_0005072
part of: A-AFFY-44

BCL2A1
type: EnsemblDatabaseReference

(Sample) organism/Homo sapiens
type: Homo sapiens
property type: organism
property value: Homo sapiens

SATB2
type: EnsemblDatabaseReference

PFKFB3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.04289829772814
p value: 0.0156476786557066
refers to: PFKFB3
refers to: 202464_s_at
t statistic: 4.31947436959388

211101_x_at
type: EFO_0005072
part of: A-AFFY-44

IL11 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.42176243230303
p value: 0.0120550525357693
refers to: IL11
refers to: 206924_at
t statistic: 4.67021795863073

CSGALNACT1
type: EnsemblDatabaseReference

215223_s_at
type: EFO_0005072
part of: A-AFFY-44

CLEC4D
type: EnsemblDatabaseReference

SLC16A4
type: EnsemblDatabaseReference

OLR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.83760927295977
p value: 0.0130110983686065
refers to: 210004_at
refers to: OLR1
t statistic: 4.55040659198664

TAGAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.36040244562344
p value: 0.0256783189883894
refers to: TAGAP
refers to: 234050_at
t statistic: 3.81690644855574

SELL
type: EnsemblDatabaseReference

SLC25A37
type: EnsemblDatabaseReference

DGAT2
type: EnsemblDatabaseReference

PDE4B
type: EnsemblDatabaseReference

209396_s_at
type: EFO_0005072
part of: A-AFFY-44

FFAR2
type: EnsemblDatabaseReference

IL11
type: EnsemblDatabaseReference

205159_at
type: EFO_0005072
part of: A-AFFY-44

RP11-373D23.2
type: EnsemblDatabaseReference

TWIST1
type: EnsemblDatabaseReference

LILRA5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.45577829650361
p value: 0.0200424130152393
refers to: LILRA5
refers to: 215838_at
t statistic: 4.04436369344117

213456_at
type: EFO_0005072
part of: A-AFFY-44

CMTM2
type: EnsemblDatabaseReference

FCAR UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.54270797667778
p value: 0.0219373377326444
refers to: FCAR
refers to: 207674_at
t statistic: 3.94943306948979

1555963_x_at
type: EFO_0005072
part of: A-AFFY-44

TNFRSF10C UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.76569163668264
p value: 0.00610411881782526
refers to: TNFRSF10C
refers to: 211163_s_at
t statistic: 5.34725118060537

202464_s_at
type: EFO_0005072
part of: A-AFFY-44

MCEMP1
type: EnsemblDatabaseReference

CDHR1
type: EnsemblDatabaseReference

PTGES UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.21404041361666
p value: 0.0156476786557066
refers to: PTGES
refers to: 210367_s_at
t statistic: 4.32011705127313

ZFP36 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.11107385172112
p value: 0.0112535122462482
refers to: ZFP36
refers to: 201531_at
t statistic: 4.76013107536118

DUSP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.14091455876238
p value: 0.00817292338038492
refers to: DUSP1
refers to: 201041_s_at
t statistic: 5.09620420605588

218002_s_at
type: EFO_0005072
part of: A-AFFY-44

204932_at
type: EFO_0005072
part of: A-AFFY-44

HGF
type: EnsemblDatabaseReference

229584_at
type: EFO_0005072
part of: A-AFFY-44

HGF UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15920940627856
p value: 0.011224172610393
refers to: HGF
refers to: 209960_at
t statistic: 4.77346913722532

IL6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.0951096104519
p value: 0.0143276017267149
refers to: 205207_at
refers to: IL6
t statistic: 4.41701110193564

LILRA5
type: EnsemblDatabaseReference

BASP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.32807032088744
p value: 0.0226228835390257
refers to: 202391_at
refers to: BASP1
t statistic: 3.92919895376173

230585_at
type: EFO_0005072
part of: A-AFFY-44

SERPINE1
type: EnsemblDatabaseReference

(Assay) P15/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

TAGAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.44478747068715
p value: 0.0170202310953676
refers to: 1552542_s_at
refers to: TAGAP
t statistic: 4.23116539320633

CLEC4D
type: EnsemblDatabaseReference

TFPI2
type: EnsemblDatabaseReference

PYY DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.48364123211819
p value: 0.029875890469655
refers to: PYY
refers to: 207080_s_at
t statistic: -3.68568100629332

IFIT3
type: EnsemblDatabaseReference

CSF3R
type: EnsemblDatabaseReference

COL7A1
type: EnsemblDatabaseReference

IFIT2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.47713120720067
p value: 0.0130733097685999
refers to: IFIT2
refers to: 226757_at
t statistic: 4.52688959237019

CSF3R UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.987303954124
p value: 0.00413541586804458
refers to: CSF3R
refers to: 1553297_a_at
t statistic: 5.9475058263684

OSM
type: EnsemblDatabaseReference

210119_at
type: EFO_0005072
part of: A-AFFY-44

CYP26B1
type: EnsemblDatabaseReference

LCP2
type: EnsemblDatabaseReference

RP11-373D23.2
type: EnsemblDatabaseReference

NAMPT UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.08636074439569
p value: 0.0287450863535215
refers to: NAMPT
refers to: 217738_at
t statistic: 3.72322261505672

CTB-167B5.2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.12215508521179
p value: 0.023360400888641
refers to: 1556185_a_at
refers to: CTB-167B5.2
t statistic: 3.90506734088875

C5AR1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.95637523216147
p value: 0.00413541586804458
refers to: C5AR1
refers to: 220088_at
t statistic: 5.97871635452416

PRR16 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.10482475401407
p value: 0.0406011441371427
refers to: PRR16
refers to: 220014_at
t statistic: 3.42636836758003

SAMSN1
type: EnsemblDatabaseReference

FCAR
type: EnsemblDatabaseReference

209792_s_at
type: EFO_0005072
part of: A-AFFY-44

209815_at
type: EFO_0005072
part of: A-AFFY-44

210004_at
type: EFO_0005072
part of: A-AFFY-44

SLC22A4
type: EnsemblDatabaseReference

SAMSN1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.13262476387529
p value: 0.0473720981255039
refers to: SAMSN1
refers to: 220330_s_at
t statistic: 3.29056288416229

IL1B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.07373796857038
p value: 0.00403123741785531
refers to: 39402_at
refers to: IL1B
t statistic: 6.06346703243818

FCGR3B
type: EnsemblDatabaseReference

SIRPB1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00697768722533
p value: 0.0158613163122977
refers to: SIRPB1
refers to: 1554624_a_at
t statistic: 4.30679864763135

FGF2
type: EnsemblDatabaseReference

SRGN UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.41144165443372
p value: 0.00828010328609606
refers to: 201858_s_at
refers to: SRGN
t statistic: 5.03112781594995

CTB-167B5.2
type: EnsemblDatabaseReference

SERPINE1
type: EnsemblDatabaseReference

206025_s_at
type: EFO_0005072
part of: A-AFFY-44

CXCL5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 3.23178799744715
p value: 0.0165839556599434
refers to: CXCL5
refers to: 215101_s_at
t statistic: 4.25662277642371

MCTP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00714740098938
p value: 0.0270882502280859
refers to: 220122_at
refers to: MCTP1
t statistic: 3.76547437785138

FST
type: EnsemblDatabaseReference

CTHRC1
type: EnsemblDatabaseReference

CXCL8 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.93172892678233
p value: 0.00610411881782526
refers to: CXCL8
refers to: 211506_s_at
t statistic: 5.38098281561626

CEMIP
type: EnsemblDatabaseReference

225987_at
type: EFO_0005072
part of: A-AFFY-44

HOXD11 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.01540723104969
p value: 0.0182183223700302
refers to: 214604_at
refers to: HOXD11
t statistic: -4.16932621217556

PAPPA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.18647256435099
p value: 0.02127587020655
refers to: PAPPA
refers to: 224940_s_at
t statistic: 3.97806685742297

208438_s_at
type: EFO_0005072
part of: A-AFFY-44

GK
type: EnsemblDatabaseReference

WISP1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.5547661564653
p value: 0.0297203061380308
refers to: WISP1
refers to: 229802_at
t statistic: 3.6919612936603

SERPINB2
type: EnsemblDatabaseReference

WNT5A
type: EnsemblDatabaseReference

S100A9
type: EnsemblDatabaseReference

HLA-DQA1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.4202633649459
p value: 0.0419234513397511
refers to: 213831_at
refers to: HLA-DQA1
t statistic: 3.39156899531495

OLR1
type: EnsemblDatabaseReference

MGAM
type: EnsemblDatabaseReference

LCP2
type: EnsemblDatabaseReference

CDHR1 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.08081530681331
p value: 0.0382588471595949
refers to: CDHR1
refers to: 213369_at
t statistic: -3.47057753475036

PI15
type: EnsemblDatabaseReference

207275_s_at
type: EFO_0005072
part of: A-AFFY-44

SLITRK6
type: EnsemblDatabaseReference

IGFBP5
type: EnsemblDatabaseReference

CLEC7A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.80245872646008
p value: 0.0124226153541422
refers to: CLEC7A
refers to: 1555756_a_at
t statistic: 4.64892418460846

216841_s_at
type: EFO_0005072
part of: A-AFFY-44

214974_x_at
type: EFO_0005072
part of: A-AFFY-44

HSD11B1
type: EnsemblDatabaseReference

213369_at
type: EFO_0005072
part of: A-AFFY-44

GLIS3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.192772409725
p value: 0.0175243636319585
refers to: GLIS3
refers to: 229435_at
t statistic: 4.20901185590125

(Assay) P12/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

204232_at
type: EFO_0005072
part of: A-AFFY-44

206026_s_at
type: EFO_0005072
part of: A-AFFY-44

205269_at
type: EFO_0005072
part of: A-AFFY-44

CSF3
type: EnsemblDatabaseReference

MMP25
type: EnsemblDatabaseReference

FGF2
type: EnsemblDatabaseReference

SOSTDC1
type: EnsemblDatabaseReference

KCNJ15
type: EnsemblDatabaseReference

ZFP36
type: EnsemblDatabaseReference

EMR2
type: EnsemblDatabaseReference

RGS2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.28848149905533
p value: 0.00823143891437816
refers to: RGS2
refers to: 202388_at
t statistic: 5.06578737032794

211163_s_at
type: EFO_0005072
part of: A-AFFY-44

FST
type: EnsemblDatabaseReference

CTHRC1
type: EnsemblDatabaseReference

ANPEP
type: EnsemblDatabaseReference

GCA
type: EnsemblDatabaseReference

230748_at
type: EFO_0005072
part of: A-AFFY-44

39402_at
type: EFO_0005072
part of: A-AFFY-44

204457_s_at
type: EFO_0005072
part of: A-AFFY-44

GPR84
type: EnsemblDatabaseReference

205404_at
type: EFO_0005072
part of: A-AFFY-44

SOCS3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.10062289076668
p value: 0.0239537633684416
refers to: SOCS3
refers to: 206359_at
t statistic: 3.88243068802725

S100A9
type: EnsemblDatabaseReference

ITGAM
type: EnsemblDatabaseReference

202422_s_at
type: EFO_0005072
part of: A-AFFY-44

MGAM
type: EnsemblDatabaseReference

MME UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.03485111512068
p value: 0.0144204803888178
refers to: 203435_s_at
refers to: MME
t statistic: 4.3884698909206

232629_at
type: EFO_0005072
part of: A-AFFY-44

209278_s_at
type: EFO_0005072
part of: A-AFFY-44

210423_s_at
type: EFO_0005072
part of: A-AFFY-44

STC1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.44830344042153
p value: 0.00403123741785531
refers to: STC1
refers to: 204596_s_at
t statistic: 6.31183944182605

205767_at
type: EFO_0005072
part of: A-AFFY-44

SERPINE1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.51059436646389
p value: 0.0147940163219761
refers to: SERPINE1
refers to: 202628_s_at
t statistic: 4.35674430986583

PI15
type: EnsemblDatabaseReference

ACSL4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.47853605877714
p value: 0.013291992710329
refers to: ACSL4
refers to: 202422_s_at
t statistic: 4.50082720370768

205568_at
type: EFO_0005072
part of: A-AFFY-44

SELE UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.22380853680508
p value: 0.0110632614498944
refers to: SELE
refers to: 206211_at
t statistic: 4.78928544927949

TFPI
type: EnsemblDatabaseReference

226757_at
type: EFO_0005072
part of: A-AFFY-44

205270_s_at
type: EFO_0005072
part of: A-AFFY-44

KIAA1324 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.09040248649685
p value: 0.0202552260429819
refers to: 221874_at
refers to: KIAA1324
t statistic: -4.01995967803309

TMEM71
type: EnsemblDatabaseReference

226064_s_at
type: EFO_0005072
part of: A-AFFY-44

206222_at
type: EFO_0005072
part of: A-AFFY-44

SIRPB1
type: EnsemblDatabaseReference

215101_s_at
type: EFO_0005072
part of: A-AFFY-44

CSF3
type: EnsemblDatabaseReference

GBP2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.08579311895927
p value: 0.0200424130152393
refers to: GBP2
refers to: 242907_at
t statistic: 4.03616486743775

WISP1
type: EnsemblDatabaseReference

IDO1
type: EnsemblDatabaseReference

FPR2
type: EnsemblDatabaseReference

1555756_a_at
type: EFO_0005072
part of: A-AFFY-44

232068_s_at
type: EFO_0005072
part of: A-AFFY-44

PTGES
type: EnsemblDatabaseReference

BASP1
type: EnsemblDatabaseReference

238429_at
type: EFO_0005072
part of: A-AFFY-44

211506_s_at
type: EFO_0005072
part of: A-AFFY-44

LILRB2
type: EnsemblDatabaseReference

MMP3
type: EnsemblDatabaseReference

STC1
type: EnsemblDatabaseReference

ANPEP
type: EnsemblDatabaseReference

TLR1
type: EnsemblDatabaseReference

203591_s_at
type: EFO_0005072
part of: A-AFFY-44

CXCL8 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.06374395085096
p value: 0.011036959102767
refers to: CXCL8
refers to: 202859_x_at
t statistic: 4.79920542263147

210176_at
type: EFO_0005072
part of: A-AFFY-44

C5AR1
type: EnsemblDatabaseReference

PAPPA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00657825463293
p value: 0.0237905572518576
refers to: PAPPA
refers to: 224941_at
t statistic: 3.88689097601669

1553723_at
type: EFO_0005072
part of: A-AFFY-44

TREM1
type: EnsemblDatabaseReference

202859_x_at
type: EFO_0005072
part of: A-AFFY-44

ELOVL6
type: EnsemblDatabaseReference

SOD2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.22905303857745
p value: 0.0144204803888178
refers to: 215078_at
refers to: SOD2
t statistic: 4.39308246923351

203535_at
type: EFO_0005072
part of: A-AFFY-44

HLA-DQA1
type: EnsemblDatabaseReference

EREG
type: EnsemblDatabaseReference

TNFAIP3
type: EnsemblDatabaseReference

INHBA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.03750547180854
p value: 0.00998222110168294
refers to: 210511_s_at
refers to: INHBA
t statistic: 4.87136723401255

IL1RN UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.13719215656622
p value: 0.00403123741785531
refers to: IL1RN
refers to: 212657_s_at
t statistic: 6.03073967617841

LRRK2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.33005386231924
p value: 0.0189687925548096
refers to: 229584_at
refers to: LRRK2
t statistic: 4.10220639085639

MX2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.06832756363196
p value: 0.0128791154493358
refers to: 204994_at
refers to: MX2
t statistic: 4.59674655866414

SLC16A10 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15739458279418
p value: 0.0144204803888178
refers to: SLC16A10
refers to: 222939_s_at
t statistic: 4.38561673096135

S100A9 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.25539045467416
p value: 0.0126964314563236
refers to: 203535_at
refers to: S100A9
t statistic: 4.62498225566384

217738_at
type: EFO_0005072
part of: A-AFFY-44

HAL
type: EnsemblDatabaseReference

214681_at
type: EFO_0005072
part of: A-AFFY-44

KYNU UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.3779181159518
p value: 0.0375266518610482
refers to: 217388_s_at
refers to: KYNU
t statistic: 3.4893134661296

225681_at
type: EFO_0005072
part of: A-AFFY-44

F5
type: EnsemblDatabaseReference

GPR84 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.67008638774602
p value: 0.0236170232032287
refers to: 223767_at
refers to: GPR84
t statistic: 3.89815733319898

207610_s_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P27/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

CLEC4D UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.276164994801
p value: 0.0141340591590379
refers to: CLEC4D
refers to: 1552772_at
t statistic: 4.46024457138132

TMEM71
type: EnsemblDatabaseReference

ACSL4
type: EnsemblDatabaseReference

AQP9
type: EnsemblDatabaseReference

COL8A1
type: EnsemblDatabaseReference

IGSF6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.40318093161185
p value: 0.0183460372784088
refers to: IGSF6
refers to: 206420_at
t statistic: 4.14650081604753

IL1A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.85161005832289
p value: 0.0150144884130076
refers to: 210118_s_at
refers to: IL1A
t statistic: 4.34205799124908

GBP5
type: EnsemblDatabaseReference

B3GNT7
type: EnsemblDatabaseReference

CNTN3
type: EnsemblDatabaseReference

205863_at
type: EFO_0005072
part of: A-AFFY-44

201041_s_at
type: EFO_0005072
part of: A-AFFY-44

220005_at
type: EFO_0005072
part of: A-AFFY-44

205828_at
type: EFO_0005072
part of: A-AFFY-44

231879_at
type: EFO_0005072
part of: A-AFFY-44

1553297_a_at
type: EFO_0005072
part of: A-AFFY-44

207857_at
type: EFO_0005072
part of: A-AFFY-44

ZEB2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.0033199360843
p value: 0.0400189060673515
refers to: 235593_at
refers to: ZEB2
t statistic: 3.43805348538905

(Assay) P13/5mg/kg/W0 P111632
type: Assay
identifier: P13/5mg/kg/W0 P111632
has participant: A-AFFY-44

TNFRSF10C UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.16171497254035
p value: 0.0135788444199988
refers to: TNFRSF10C
refers to: 210484_s_at
t statistic: 4.48513168177568

CREB5
type: EnsemblDatabaseReference

TAGAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.38359757670701
p value: 0.018171910073811
refers to: TAGAP
refers to: 242388_x_at
t statistic: 4.17484758107222

DOK3
type: EnsemblDatabaseReference

PTGS2
type: EnsemblDatabaseReference

207008_at
type: EFO_0005072
part of: A-AFFY-44

SLC16A4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.23892364932266
p value: 0.00817292338038492
refers to: SLC16A4
refers to: 205234_at
t statistic: 5.10003635530774

(Sample) disease/ulcerative colitis
type: EFO_0000729
property type: disease
property value: ulcerative colitis

223551_at
type: EFO_0005072
part of: A-AFFY-44

TNFAIP6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.72462630049679
p value: 0.00530847066770928
refers to: TNFAIP6
refers to: 206026_s_at
t statistic: 5.61869045803574

210772_at
type: EFO_0005072
part of: A-AFFY-44

229802_at
type: EFO_0005072
part of: A-AFFY-44

SLC11A1
type: EnsemblDatabaseReference

MNDA
type: EnsemblDatabaseReference

KIAA1324
type: EnsemblDatabaseReference

KYNU
type: EnsemblDatabaseReference

229404_at
type: EFO_0005072
part of: A-AFFY-44

C10orf99
type: EnsemblDatabaseReference

EMR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.20795627668683
p value: 0.0371058908808826
refers to: EMR2
refers to: 207610_s_at
t statistic: 3.50079876772192

CXCL8
type: EnsemblDatabaseReference

CXCL5 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 3.14053336729012
p value: 0.0183460372784088
refers to: CXCL5
refers to: 214974_x_at
t statistic: 4.15263384451647

TWIST1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.42384355102266
p value: 0.00823143891437816
refers to: TWIST1
refers to: 213943_at
t statistic: 5.07538289840744

GK UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.02717035185828
p value: 0.0130110983686065
refers to: GK
refers to: 214681_at
t statistic: 4.55379446493415

LGR5 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0433363559481
p value: 0.044850651821165
refers to: LGR5
refers to: 213880_at
t statistic: -3.33734103100787

CSF2RB
type: EnsemblDatabaseReference

PTCH1
type: EnsemblDatabaseReference

NCF2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.63123994948877
p value: 0.0110632614498944
refers to: 209949_at
refers to: NCF2
t statistic: 4.79270467726434

S100A12 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 3.29334887754671
p value: 0.00988418272501068
refers to: 205863_at
refers to: S100A12
t statistic: 4.88677598761763

NCF2
type: EnsemblDatabaseReference

201963_at
type: EFO_0005072
part of: A-AFFY-44

FAP UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.15209565290193
p value: 0.0185924735288708
refers to: 209955_s_at
refers to: FAP
t statistic: 4.12827650558892

211122_s_at
type: EFO_0005072
part of: A-AFFY-44

DGAT2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.001308437082
p value: 0.0108415595854027
refers to: DGAT2
refers to: 226064_s_at
t statistic: 4.81886788478108

SELE
type: EnsemblDatabaseReference

1552772_at
type: EFO_0005072
part of: A-AFFY-44

224940_s_at
type: EFO_0005072
part of: A-AFFY-44

SOD2
type: EnsemblDatabaseReference

208121_s_at
type: EFO_0005072
part of: A-AFFY-44

KIAA1551
type: EnsemblDatabaseReference

MX2
type: EnsemblDatabaseReference

CHI3L1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.89866368527654
p value: 0.0248793078365628
refers to: 209395_at
refers to: CHI3L1
t statistic: 3.84492700273796

IL1RN UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.68272181755594
p value: 0.00592109695122305
refers to: IL1RN
refers to: 212659_s_at
t statistic: 5.43539860760045

OLFM1
type: EnsemblDatabaseReference

PTGS2
type: EnsemblDatabaseReference

209949_at
type: EFO_0005072
part of: A-AFFY-44

PLEK UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.92270246008872
p value: 0.00990826585544117
refers to: 203471_s_at
refers to: PLEK
t statistic: 4.88258262991812

238623_at
type: EFO_0005072
part of: A-AFFY-44

TWIST2
type: EnsemblDatabaseReference

AQP9 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.70595662492392
p value: 0.00413541586804458
refers to: AQP9
refers to: 205568_at
t statistic: 5.96986541096974

TLR8 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.49824508417226
p value: 0.0128806085713221
refers to: TLR8
refers to: 229560_at
t statistic: 4.58040877085046

CCL4
type: EnsemblDatabaseReference

IL24
type: EnsemblDatabaseReference

1555638_a_at
type: EFO_0005072
part of: A-AFFY-44

MNDA
type: EnsemblDatabaseReference

210664_s_at
type: EFO_0005072
part of: A-AFFY-44

COL8A1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.41205011137277
p value: 0.0311412472938025
refers to: COL8A1
refers to: 226237_at
t statistic: 3.65270280222664

TNFRSF10C UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2011465992502
p value: 0.0120550525357693
refers to: TNFRSF10C
refers to: 206222_at
t statistic: 4.69747463368093

KCNJ15 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.37083826655474
p value: 0.00530847066770928
refers to: KCNJ15
refers to: 210119_at
t statistic: 5.60726515553337

205922_at
type: EFO_0005072
part of: A-AFFY-44

PDE4B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.54128875576804
p value: 0.0216251248567441
refers to: PDE4B
refers to: 211302_s_at
t statistic: 3.95740607756698

211958_at
type: EFO_0005072
part of: A-AFFY-44

STEAP4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.0151725940922
p value: 0.0406011441371427
refers to: 220187_at
refers to: STEAP4
t statistic: 3.42574804473019

CHI3L1
type: EnsemblDatabaseReference

FPR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.32503315750783
p value: 0.00481152921127824
refers to: 210773_s_at
refers to: FPR2
t statistic: 5.75783714099219

219970_at
type: EFO_0005072
part of: A-AFFY-44

TNFRSF10C
type: EnsemblDatabaseReference

THBS2
type: EnsemblDatabaseReference

ALPL
type: EnsemblDatabaseReference

NAMPT
type: EnsemblDatabaseReference

HAPLN1
type: EnsemblDatabaseReference

GLIS3
type: EnsemblDatabaseReference

WNT5A UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46265222697525
p value: 0.0128791154493358
refers to: WNT5A
refers to: 213425_at
t statistic: 4.58496122652923

CXCL14
type: EnsemblDatabaseReference

MNDA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.30010587972529
p value: 0.00890505338550303
refers to: MNDA
refers to: 204959_at
t statistic: 4.97235384183923

CYP4F3
type: EnsemblDatabaseReference

FCER1G UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.14185377706289
p value: 0.0104335931311093
refers to: FCER1G
refers to: 204232_at
t statistic: 4.84628069731581

GPR27
type: EnsemblDatabaseReference

WFDC2
type: EnsemblDatabaseReference

EREG UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.74864156541612
p value: 0.02160111564107
refers to: 205767_at
refers to: EREG
t statistic: 3.96281271429913

(Assay) P32/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

PRR16
type: EnsemblDatabaseReference

PKIB DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.51862987542912
p value: 0.0372900714403981
refers to: 223551_at
refers to: PKIB
t statistic: -3.49352163631091

PLEK UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.54436635084447
p value: 0.0143276017267149
refers to: PLEK
refers to: 203470_s_at
t statistic: 4.41827710488424

ITGAX
type: EnsemblDatabaseReference

(Assay) P13/5mg/kg/W0 P111633
type: Assay
identifier: P13/5mg/kg/W0 P111633
has participant: A-AFFY-44

210997_at
type: EFO_0005072
part of: A-AFFY-44

228758_at
type: EFO_0005072
part of: A-AFFY-44

205237_at
type: EFO_0005072
part of: A-AFFY-44

213733_at
type: EFO_0005072
part of: A-AFFY-44

FAP
type: EnsemblDatabaseReference

CYP26B1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.01267347690703
p value: 0.0120550525357693
refers to: CYP26B1
refers to: 219825_at
t statistic: 4.69743119597069

204563_at
type: EFO_0005072
part of: A-AFFY-44

FPR1
type: EnsemblDatabaseReference

203708_at
type: EFO_0005072
part of: A-AFFY-44

CXCL11
type: EnsemblDatabaseReference

204614_at
type: EFO_0005072
part of: A-AFFY-44

STC1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.73680633388045
p value: 0.00403123741785531
refers to: 204595_s_at
refers to: STC1
t statistic: 6.02601423914066

206643_at
type: EFO_0005072
part of: A-AFFY-44

FGF2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.29162116131415
p value: 0.0185886066115482
refers to: FGF2
refers to: 204422_s_at
t statistic: 4.13548054307835

ACSL1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.09926481975006
p value: 0.00530847066770928
refers to: ACSL1
refers to: 201963_at
t statistic: 5.62800782505297

MGAM UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.18999939832268
p value: 0.0120550525357693
refers to: MGAM
refers to: 206522_at
t statistic: 4.67469676560236

NFIL3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.05064767804049
p value: 0.0120550525357693
refers to: NFIL3
refers to: 203574_at
t statistic: 4.66825732638564

GPR97 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.29255680537733
p value: 0.0124865437899714
refers to: 1553723_at
refers to: GPR97
t statistic: 4.63588331362364

LCP2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22093412194029
p value: 0.0426851796119801
refers to: 205269_at
refers to: LCP2
t statistic: 3.37916358657395

LRRK2
type: EnsemblDatabaseReference

TNFRSF11B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.99450568651413
p value: 0.00413541586804458
refers to: 204932_at
refers to: TNFRSF11B
t statistic: 5.8926310305355

RGS2
type: EnsemblDatabaseReference

243296_at
type: EFO_0005072
part of: A-AFFY-44

GLIS3
type: EnsemblDatabaseReference

207697_x_at
type: EFO_0005072
part of: A-AFFY-44

SLC2A3
type: EnsemblDatabaseReference

PDE4B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.46110832196904
p value: 0.0183460372784088
refers to: PDE4B
refers to: 203708_at
t statistic: 4.14929015432591

203470_s_at
type: EFO_0005072
part of: A-AFFY-44

VNN2
type: EnsemblDatabaseReference

NRCAM
type: EnsemblDatabaseReference

LILRA2
type: EnsemblDatabaseReference

228128_x_at
type: EFO_0005072
part of: A-AFFY-44

MASP1
type: EnsemblDatabaseReference

SLC2A3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.67655003457559
p value: 0.0251790139810018
refers to: SLC2A3
refers to: 202498_s_at
t statistic: 3.83872708841267

IFIT2
type: EnsemblDatabaseReference

RNF144B
type: EnsemblDatabaseReference

LGR5
type: EnsemblDatabaseReference

221345_at
type: EFO_0005072
part of: A-AFFY-44

SATB2
type: EnsemblDatabaseReference

209930_s_at
type: EFO_0005072
part of: A-AFFY-44

CSGALNACT1
type: EnsemblDatabaseReference

SLC16A4
type: EnsemblDatabaseReference

S100A8
type: EnsemblDatabaseReference

SELL
type: EnsemblDatabaseReference

SLC25A37
type: EnsemblDatabaseReference

DGAT2
type: EnsemblDatabaseReference

210873_x_at
type: EFO_0005072
part of: A-AFFY-44

222934_s_at
type: EFO_0005072
part of: A-AFFY-44

KLK10 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.33063694777487
p value: 0.0189532993038187
refers to: 209792_s_at
refers to: KLK10
t statistic: 4.10386866371258

PDE4B
type: EnsemblDatabaseReference

MMP19
type: EnsemblDatabaseReference

HCK
type: EnsemblDatabaseReference

FFAR2
type: EnsemblDatabaseReference

213831_at
type: EFO_0005072
part of: A-AFFY-44

220187_at
type: EFO_0005072
part of: A-AFFY-44

205119_s_at
type: EFO_0005072
part of: A-AFFY-44

IDO1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.4364991658991
p value: 0.0432071628006719
refers to: 210029_at
refers to: IDO1
t statistic: 3.36789768192444

STC1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.9349127229114
p value: 0.00403123741785531
refers to: STC1
refers to: 204597_x_at
t statistic: 6.02636700501399

(Assay) P9/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

CMTM2
type: EnsemblDatabaseReference

HOXD11
type: EnsemblDatabaseReference

203471_s_at
type: EFO_0005072
part of: A-AFFY-44

GIPC2
type: EnsemblDatabaseReference

203140_at
type: EFO_0005072
part of: A-AFFY-44

TLR2
type: EnsemblDatabaseReference

CSF2RB UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.06431402105426
p value: 0.0367518440689814
refers to: CSF2RB
refers to: 205159_at
t statistic: 3.50948815897398

219434_at
type: EFO_0005072
part of: A-AFFY-44

MCEMP1
type: EnsemblDatabaseReference

MMP19 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.00335556507363
p value: 0.027402972771999
refers to: 204575_s_at
refers to: MMP19
t statistic: 3.75922282581841

SLC16A10
type: EnsemblDatabaseReference

SLC2A3
type: EnsemblDatabaseReference

205083_at
type: EFO_0005072
part of: A-AFFY-44

CCL4 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.26176855995575
p value: 0.0313295322375933
refers to: CCL4
refers to: 204103_at
t statistic: 3.63532803793642

SPP1
type: EnsemblDatabaseReference

RNF144B
type: EnsemblDatabaseReference

228153_at
type: EFO_0005072
part of: A-AFFY-44

S100A8 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.350595433958
p value: 0.0236526986837194
refers to: S100A8
refers to: 202917_s_at
t statistic: 3.8932528356977

IFIT3
type: EnsemblDatabaseReference

220088_at
type: EFO_0005072
part of: A-AFFY-44

ELOVL6 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0188325104541
p value: 0.0459121284443378
refers to: ELOVL6
refers to: 210868_s_at
t statistic: -3.31961859197642

1554624_a_at
type: EFO_0005072
part of: A-AFFY-44

COL7A1
type: EnsemblDatabaseReference

MMP19
type: EnsemblDatabaseReference

INHBA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.29131057539013
p value: 0.0144204803888178
refers to: INHBA
refers to: 227140_at
t statistic: 4.37807585655874

OSM
type: EnsemblDatabaseReference

CYP26B1
type: EnsemblDatabaseReference

229723_at
type: EFO_0005072
part of: A-AFFY-44

PKIB
type: EnsemblDatabaseReference

(Factor value) CLINICAL_INFORMATION/no response to Infliximab
type: EFO_0000001
property type: CLINICAL_INFORMATION
property value: no response to Infliximab

TNFRSF11B
type: EnsemblDatabaseReference

GIPC2
type: EnsemblDatabaseReference

SAMSN1
type: EnsemblDatabaseReference

TLR2
type: EnsemblDatabaseReference

FCAR
type: EnsemblDatabaseReference

SLC22A4
type: EnsemblDatabaseReference

235593_at
type: EFO_0005072
part of: A-AFFY-44

FCGR3B
type: EnsemblDatabaseReference

IL1RN
type: EnsemblDatabaseReference

TLR8
type: EnsemblDatabaseReference

CTB-167B5.2
type: EnsemblDatabaseReference

RP3-428L16.2
type: EnsemblDatabaseReference

STEAP4
type: EnsemblDatabaseReference

PROK2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 3.14818538720794
p value: 0.00563302224804152
refers to: 232629_at
refers to: PROK2
t statistic: 5.48927770335319

BCL6 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.63350333903603
p value: 0.011224172610393
refers to: BCL6
refers to: 228758_at
t statistic: 4.77458019319485

SLC16A6
type: EnsemblDatabaseReference

(Assay) P28/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

GBP2
type: EnsemblDatabaseReference

AOX1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.1966268996013
p value: 0.0143276017267149
refers to: 205083_at
refers to: AOX1
t statistic: 4.41372341848792

CEMIP
type: EnsemblDatabaseReference

203765_at
type: EFO_0005072
part of: A-AFFY-44

SERPINE1 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.30252189891724
p value: 0.0147459046709654
refers to: 202627_s_at
refers to: SERPINE1
t statistic: 4.35931271043667

IL1B UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.18337749147895
p value: 0.00403123741785531
refers to: IL1B
refers to: 205067_at
t statistic: 6.07019673729042

202498_s_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P19/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

LILRA2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.45605154038811
p value: 0.0120550525357693
refers to: 207857_at
refers to: LILRA2
t statistic: 4.68671890532725

GK
type: EnsemblDatabaseReference

202497_x_at
type: EFO_0005072
part of: A-AFFY-44

SERPINB2
type: EnsemblDatabaseReference

WNT5A
type: EnsemblDatabaseReference

(Assay) P16/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

CCR1
type: EnsemblDatabaseReference

241824_at
type: EFO_0005072
part of: A-AFFY-44

212659_s_at
type: EFO_0005072
part of: A-AFFY-44

221477_s_at
type: EFO_0005072
part of: A-AFFY-44

PKIB
type: EnsemblDatabaseReference

NFIL3
type: EnsemblDatabaseReference

SLITRK6 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04534701705379
p value: 0.0245455423203746
refers to: 232481_s_at
refers to: SLITRK6
t statistic: -3.85740746124854

IL1A
type: EnsemblDatabaseReference

P2RY13
type: EnsemblDatabaseReference

SLITRK6
type: EnsemblDatabaseReference

TNFRSF11B
type: EnsemblDatabaseReference

(Assay) P17/10mg/kg/W0
type: Assay
has participant: A-AFFY-44

VNN2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.03085050245016
p value: 0.0113818715201421
refers to: VNN2
refers to: 205922_at
t statistic: 4.74382105594546

TFPI2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.57034227323768
p value: 0.0324413401944569
refers to: TFPI2
refers to: 209277_at
t statistic: 3.60765775501849

CXCL5
type: EnsemblDatabaseReference

202917_s_at
type: EFO_0005072
part of: A-AFFY-44

KLK10
type: EnsemblDatabaseReference

IL1RN
type: EnsemblDatabaseReference

MMP25
type: EnsemblDatabaseReference

SOSTDC1
type: EnsemblDatabaseReference

RP3-428L16.2
type: EnsemblDatabaseReference

202499_s_at
type: EFO_0005072
part of: A-AFFY-44

ZFP36
type: EnsemblDatabaseReference

NFE2
type: EnsemblDatabaseReference

A-AFFY-44
type: EFO_0000269

SLC16A6
type: EnsemblDatabaseReference

EMR2
type: EnsemblDatabaseReference

ITGAM UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.21177204302356
p value: 0.0204352575963548
refers to: ITGAM
refers to: 205786_s_at
t statistic: 4.01288984963934

206515_at
type: EFO_0005072
part of: A-AFFY-44

IL18RAP
type: EnsemblDatabaseReference

PAPPA UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.39522501106479
p value: 0.030190621350093
refers to: 228128_x_at
refers to: PAPPA
t statistic: 3.67838517590769

Homo sapiens
type: OBI_0100026

209955_s_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P29/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

PTCH1 DOWN in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: DecreasedDifferentialExpressionRatio
fold change: -1.00015183665708
p value: 0.0255793981254183
refers to: 209815_at
refers to: PTCH1
t statistic: -3.82622368050566

GCA
type: EnsemblDatabaseReference

BCL6
type: EnsemblDatabaseReference

PYY
type: EnsemblDatabaseReference

206765_at
type: EFO_0005072
part of: A-AFFY-44

ALOX5AP
type: EnsemblDatabaseReference

FFAR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.24138831450171
p value: 0.00823143891437816
refers to: FFAR2
refers to: 221345_at
t statistic: 5.05197451677831

RGS18
type: EnsemblDatabaseReference

LILRB2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.68041098768595
p value: 0.0183460372784088
refers to: LILRB2
refers to: 210146_x_at
t statistic: 4.15240101991429

GPR84
type: EnsemblDatabaseReference

CXCR2 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 2.71267936724858
p value: 0.00488495392780098
refers to: CXCR2
refers to: 207008_at
t statistic: 5.73783616072113

CSF3 UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.29526283495067
p value: 0.026483334203047
refers to: CSF3
refers to: 207442_at
t statistic: 3.78984642221582

ITGAM
type: EnsemblDatabaseReference

201531_at
type: EFO_0005072
part of: A-AFFY-44

(Assay) P33/5mg/kg/W0
type: Assay
has participant: A-AFFY-44

CCR1
type: EnsemblDatabaseReference

204105_s_at
type: EFO_0005072
part of: A-AFFY-44

CLEC4D UP in 'no response to Infliximab' vs 'response to Infliximab treatment'
type: IncreasedDifferentialExpressionRatio
fold change: 1.14912409735933
p value: 0.0160598420557361
refers to: CLEC4D
refers to: 1552773_at
t statistic: 4.28534970788625